rxstat › Classes › Antimycotics For Systemic Use

Antimycotics For Systemic Use: shortage status in Canada

4 of the 9 antimycotics for systemic use rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Micafungin (Mycamine) Widespread shortage 2 of 3 reported products affected Caspofungin (Cancidas) Partial shortage 1 of 6 reported products affected · est. return Oct 30, 2027 Fluconazole (Diflucan) Partial shortage 4 of 19 reported products affected · est. return Apr 13, 2027 Voriconazole (Vfend) Partial shortage 1 of 12 reported products affected Amphotericin B (Fungizone Intravenous) No current shortage Itraconazole (Sporanox) No current shortage Ketoconazole (Ketoderm) No current shortage Micafungin No current shortage Posaconazole (Posanol) No current shortage

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.